undamentalytics Newsletter
Sign in

Lensar, Inc. revenue

Lensar, Inc.'s revenue was $58.4m in fiscal 2025, up 9.2% on the year before. Since fiscal 2019 ($30.5m) it has grown at a compound 11.4% a year. Over the last twelve months it was $60.3m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue3126343542535860
Growth on the year before—−13.6%+30.6%+2.6%+19.2%+26.9%+9.2%—
Gross profit1314182021262729
Gross margin43.3%53.4%51.8%56.4%50.1%48.3%46.4%48.3%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue YoY
Products $45.9M ▲ 11.8%
Services $5.7M ▲ 17.0%

These categories overlap or exclude eliminations, so shares aren't shown.

Geography
Region Revenue YoY
United States $34.3M ▲ 18.7%
Europe $8.4M ▼ 17.0%
Asia Excluding South Korea $8M ▲ 46.2%
South Korea $658,000 ▼ 22.4%
Other Geographical Region $238,000 ▼ 57.7%

These categories overlap or exclude eliminations, so shares aren't shown.

From Lensar, Inc.'s 10-K filed March 31, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Lensar, Inc. $60.3m 3.3% 16.4%
Cvrx, Inc. $61.2m 12.0% 25.7%
Alpha PRO Tech LTD $61.9m 5.7% 2.9%
Apyx Medical Corp $58.4m 25.6% 7.2%
Iridex Corp $51.6m 3.7% -2.9%
Electromed, Inc. $73.8m 15.3% 15.4%

Compare with peers

Head to head: CVRX vs LNSRAPT vs LNSRAPYX vs LNSR

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Lensar, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Lensar, Inc.